Fulgent Genetics, Inc. (FLGT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 150M 300M 450M Q3 '16: 5M Q4 '16: 5.9M Q1 '17: 5.3M Q2 '17: 4.6M Q3 '17: 4.5M Q4 '17: 4.3M Q1 '18: 4.7M Q2 '18: 5.4M Q3 '18: 5.6M Q4 '18: 5.7M Q1 '19: 5.4M Q2 '19: 8.4M Q3 '19: 10.3M Q4 '19: 8.4M Q1 '20: 7.8M Q2 '20: 17.3M Q3 '20: 101.7M Q4 '20: 295M Q1 '21: 359.4M Q2 '21: 153.6M Q3 '21: 227.9M Q4 '21: 251.7M Q1 '22: 320.3M Q2 '22: 125.3M Q3 '22: 105.7M Q4 '22: 67.7M Q1 '23: 66.2M Q2 '23: 67.9M Q3 '23: 84.7M Q4 '23: 70.5M Q1 '24: 64.5M Q2 '24: 71M Q3 '24: 71.7M Q4 '24: 76.2M Q1 '25: 73.5M Q2 '25: 81.8M Q3 '25: 84.1M Q4 '25: 83.3M Q1 '26: 71.1M Q2 '26: 85.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 100M 200M 300M Q3 '16: 2.9M Q4 '16: 4M Q1 '17: 3.4M Q2 '17: 2.8M Q3 '17: 2.2M Q4 '17: 1.7M Q1 '18: 1.9M Q2 '18: 2.9M Q3 '18: 3M Q4 '18: 2.9M Q1 '19: 2.4M Q2 '19: 4.8M Q3 '19: 6.5M Q4 '19: 4.8M Q1 '20: 3.7M Q2 '20: 9.5M Q3 '20: 75.5M Q4 '20: 243.2M Q1 '21: 285.4M Q2 '21: 117.8M Q3 '21: 184.4M Q4 '21: 189.5M Q1 '22: 242.5M Q2 '22: 65.3M Q3 '22: 46.1M Q4 '22: 13M Q1 '23: 18.8M Q2 '23: 20.6M Q3 '23: 39.8M Q4 '23: 25.2M Q1 '24: 22.1M Q2 '24: 26.5M Q3 '24: 26.8M Q4 '24: 31.8M Q1 '25: 28.3M Q2 '25: 34.4M Q3 '25: 35.5M Q4 '25: 32.6M Q1 '26: 21.5M Q2 '26: 25.7M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income Quarterly

-200M -100M 0 100M 200M 300M Q3 '16: -695K Q4 '16: 1.3M Q1 '17: 219K Q2 '17: -150K Q3 '17: -1.5M Q4 '17: -2.1M Q1 '18: -2.2M Q2 '18: -1M Q3 '18: -846K Q4 '18: -1M Q1 '19: -1.8M Q2 '19: 295K Q3 '19: 1.5M Q4 '19: -409K Q1 '20: -1.9M Q2 '20: 2.6M Q3 '20: 63.5M Q4 '20: 225.9M Q1 '21: 266.9M Q2 '21: 98.9M Q3 '21: 159.3M Q4 '21: 150.9M Q1 '22: 201.9M Q2 '22: 12.8M Q3 '22: 352K Q4 '22: -36.6M Q1 '23: -24.8M Q2 '23: -19.8M Q3 '23: 214K Q4 '23: -151.1M Q1 '24: -21.8M Q2 '24: -18.9M Q3 '24: -17.1M Q4 '24: -16.1M Q1 '25: -19.8M Q2 '25: -19.7M Q3 '25: -15.3M Q4 '25: -36.2M Q1 '26: -34.6M Q2 '26: -36.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-140M -70M 0 70M 140M 210M Q3 '16: -1.1M Q4 '16: 813K Q1 '17: 232K Q2 '17: -25K Q3 '17: -1.1M Q4 '17: -1.6M Q1 '18: -1.9M Q2 '18: -1M Q3 '18: -595K Q4 '18: -2.1M Q1 '19: -1.9M Q2 '19: 331K Q3 '19: 1.5M Q4 '19: -296K Q1 '20: -2M Q2 '20: 3.3M Q3 '20: 46.6M Q4 '20: 166.3M Q1 '21: 200.7M Q2 '21: 79.8M Q3 '21: 122.5M Q4 '21: 104.3M Q1 '22: 154M Q2 '22: 11.5M Q3 '22: 1.7M Q4 '22: -23.8M Q1 '23: -15.3M Q2 '23: -11.2M Q3 '23: -13.1M Q4 '23: -128.1M Q1 '24: -13.5M Q2 '24: -8.7M Q3 '24: -14.6M Q4 '24: -5.9M Q1 '25: -11.5M Q2 '25: -19M Q3 '25: -6.6M Q4 '25: -23.4M Q1 '26: -24.8M Q2 '26: -29.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 30M 60M 90M Q3 '16: 2.1M Q4 '16: 1.9M Q1 '17: 1.9M Q2 '17: 1.9M Q3 '17: 2.3M Q4 '17: 2.5M Q1 '18: 2.8M Q2 '18: 2.5M Q3 '18: 2.6M Q4 '18: 2.8M Q1 '19: 3M Q2 '19: 3.6M Q3 '19: 3.9M Q4 '19: 3.6M Q1 '20: 4.1M Q2 '20: 7.7M Q3 '20: 26.3M Q4 '20: 51.8M Q1 '21: 74.1M Q2 '21: 35.9M Q3 '21: 43.5M Q4 '21: 62.1M Q1 '22: 77.7M Q2 '22: 60.1M Q3 '22: 59.6M Q4 '22: 54.7M Q1 '23: 47.4M Q2 '23: 47.3M Q3 '23: 44.8M Q4 '23: 45.3M Q1 '24: 42.4M Q2 '24: 44.5M Q3 '24: 45M Q4 '24: 44.4M Q1 '25: 45.1M Q2 '25: 47.4M Q3 '25: 48.6M Q4 '25: 50.8M Q1 '26: 49.6M Q2 '26: 59.7M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-80M 0 80M 160M 240M Q1 '16: 875K Q2 '16: 1.5M Q3 '16: 798K Q4 '16: 1.3M Q1 '17: 1.5M Q2 '17: 564K Q3 '17: 500K Q1 '18: -1.3M Q2 '18: -57K Q3 '18: -105K Q1 '19: 1.1M Q2 '19: 675K Q3 '19: 3.9M Q4 '19: -116K Q1 '20: 1.4M Q2 '20: -4.4M Q3 '20: 9.4M Q4 '20: 134.3M Q1 '21: 233.2M Q2 '21: 76.1M Q3 '21: 152.2M Q4 '21: 77.1M Q1 '22: 188.4M Q2 '22: 11.1M Q3 '22: 20.8M Q4 '22: 33.2M Q1 '23: -7.9M Q2 '23: 9.7M Q3 '23: 10.2M Q4 '23: 14.9M Q1 '24: 7.3M Q2 '24: 4.3M Q3 '24: -15.5M Q4 '24: 25M Q1 '25: -4.4M Q2 '25: -30.2M Q3 '25: 11.1M Q4 '25: -78.1M Q1 '26: 7.1M Q2 '26: -23.8M Q1 '17 Q3 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-160M -80M 0 80M 160M 240M Q1 '16: 698K Q2 '16: 1.1M Q3 '16: -2M Q4 '16: 845K Q1 '17: 1.4M Q2 '17: -863K Q3 '17: 263K Q1 '18: -2.4M Q2 '18: -93K Q3 '18: -1.2M Q1 '19: 921K Q2 '19: 176K Q3 '19: 3.8M Q4 '19: -577K Q1 '20: 570K Q2 '20: -4.8M Q3 '20: -714K Q4 '20: 110.5M Q1 '21: 221.7M Q2 '21: 73.2M Q3 '21: 148.8M Q4 '21: 71.1M Q1 '22: 183.1M Q2 '22: 7.9M Q3 '22: 15.3M Q4 '22: 28.5M Q1 '23: -9.9M Q2 '23: -2.4M Q3 '23: 5.3M Q4 '23: 11.8M Q1 '24: 3.2M Q2 '24: -8.7M Q3 '24: -35M Q4 '24: 21.2M Q1 '25: -9.1M Q2 '25: -37M Q3 '25: 5.1M Q4 '25: -83.1M Q1 '26: 1.9M Q2 '26: -27.6M Q1 '17 Q3 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '16: 12.1M Q2 '16: 12.4K Q3 '16: 12.8M Q1 '17: 18.2M Q2 '17: 17.7M Q3 '17: 17.8M Q1 '18: 17.9M Q2 '18: 17.9M Q3 '18: 18M Q1 '19: 18.2M Q2 '19: 19M Q3 '19: 19.5M Q1 '20: 21.6M Q2 '20: 22.9M Q3 '20: 23.5M Q1 '21: 30.8M Q2 '21: 30.8M Q3 '21: 31.2M Q1 '22: 31.2M Q2 '22: 31.2M Q3 '22: 30.9M Q1 '23: 29.5M Q2 '23: 29.8M Q3 '23: 30M Q1 '24: 29.8M Q2 '24: 30.1M Q3 '24: 30.4M Q1 '25: 30.8M Q2 '25: 30.5M Q3 '25: 30.7M Q1 '26: 30.9M Q2 '26: 28M Q1 '17 Q2 '18 Q3 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q3 '17: 0.00 Q4 '17: -0.14 Q1 '18: -0.26 Q2 '18: -0.32 Q3 '18: -0.29 Q4 '18: -0.31 Q3 '17 Q4 '17 Q1 '18 Q2 '18 Q3 '18 Q4 '18

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.